Literature DB >> 23622775

Reply to C. Mary Schooling, Grace Sembajwe and Ilir Agalliu's letter to the editor Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study.

Christina Gade Jespersen, Mette Nørgaard, Michael Borre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23622775     DOI： 10.1016/j.eururo.2013.04.016

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  4 in total

1.  Risk of cardiovascular thrombotic events after surgical castration versus gonadotropin-releasing hormone agonists in Chinese men with prostate cancer.

Authors:  Jeremy Yc Teoh; Samson Ys Chan; Peter Kf Chiu; Darren Mc Poon; Ho-Yuen Cheung; Simon Sm Hou; Chi-Fai Ng
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

2.  Androgen deprivation therapy for prostate cancer is associated with cardiovascular morbidity and mortality: a meta-analysis of population-based observational studies.

Authors:  Jinsheng Zhao; Shimiao Zhu; Libin Sun; Fanzheng Meng; Lin Zhao; Yusheng Zhao; Hao Tian; Ping Li; Yuanjie Niu
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

Review 3.  Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis.

Authors:  Tobias Engel Ayer Botrel; Otávio Clark; Rodolfo Borges dos Reis; Antônio Carlos Lima Pompeo; Ubirajara Ferreira; Marcus Vinicius Sadi; Francisco Flávio Horta Bretas
Journal:  BMC Urol       Date:  2014-01-25       Impact factor: 2.264

Review 4.  Stroke related to androgen deprivation therapy for prostate cancer: a meta-analysis and systematic review.

Authors:  Fanzheng Meng; Shimiao Zhu; Jinsheng Zhao; Larissa Vados; Lei Wang; Yusheng Zhao; Dan Zhao; Yuanjie Niu
Journal:  BMC Cancer       Date:  2016-03-03       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.